Literature DB >> 24629809

Breast-conserving surgery after neoadjuvant chemotherapy in patients with locally advanced cancer. Preliminary results.

M Vergine, P Scipioni, S Garritano, M Colangelo, A Di Paolo, G Livadoti, A Maturo, M Monti.   

Abstract

Neoadjuvant chemotherapy (NACT) in locally advanced breast tumors may allow an adequate control of the disease impossible with surgery alone. Moreover, NACT increases the chance of breast-conserving surgery. Between 2008 and 2012, we treated with NACT 83 patients with locally advanced breast cancer. We report the preliminary results evaluating the impact of NACT on the type of surgery.

Entities:  

Mesh：

Year:  2013        PMID： 24629809      PMCID： PMC3926477     

Source DB:  PubMed          Journal:  G Chir        ISSN： 0391-9005


  21 in total

1.  The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.

Authors:  Pauline T Truong; Wendy A Woodward; Howard D Thames; Joseph Ragaz; Ivo A Olivotto; Thomas A Buchholz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-22       Impact factor: 7.038

2.  Local recurrence and the deep resection margin in carcinoma of the breast.

Authors:  S J Mentzer; R T Osteen; R E Wilson
Journal:  Surg Gynecol Obstet       Date:  1986-12

3.  Decreased survival related to irradiation postoperatively in early operable breast cancer.

Authors:  J Stjernswärd
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

4.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer.

Authors:  J Lacour; M Le; E Caceres; T Koszarowski; U Veronesi; C Hill
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

5.  Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.

Authors:  D Stefanik; R Goldberg; P Byrne; F Smith; W Ueno; L Smith; L Bachenheimer; C Beiser; A Dritschilo
Journal:  J Clin Oncol       Date:  1985-05       Impact factor: 44.544

6.  A biostatistical study of locally recurrent breast carcinoma.

Authors:  W L Donegan; C M Perez-Mesa; F R Watson
Journal:  Surg Gynecol Obstet       Date:  1966-03

7.  Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.

Authors:  A Recht; R Gray; N E Davidson; B L Fowble; L J Solin; F J Cummings; G Falkson; H C Falkson; S G Taylor; D C Tormey
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

8.  Status of postmastectomy radiotherapy in the United States: a patterns of care study.

Authors:  Julia White; Jennifer Moughan; Lori J Pierce; Monica Morrow; Jean Owen; J Frank Wilson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

9.  Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.

Authors:  Alphonse Taghian; Jong-Hyeon Jeong; Eleftherios Mamounas; Stewart Anderson; John Bryant; Melvin Deutsch; Norman Wolmark
Journal:  J Clin Oncol       Date:  2004-09-27       Impact factor: 44.544

10.  The significance of local recurrence of carcinoma of the breast.

Authors:  L M Toonkel; I Fix; L H Jacobson; C B Wallach
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-01       Impact factor: 7.038
View more
  3 in total

1.  Predictors of Surgery Types after Neoadjuvant Therapy for Advanced Stage Breast Cancer: Analysis from Florida Population-Based Cancer Registry (1996-2009).

Authors:  Jamila Al-Azhri; Tulay Koru-Sengul; Feng Miao; Constantine Saclarides; Margaret M Byrne; Eli Avisar
Journal:  Breast Cancer (Auckl)       Date:  2015-12-13

2.  FOXN4 Inhibits Breast Cancer Progression By Direct Activation Of P53.

Authors:  Hui Ye; Meiling Duan
Journal:  Onco Targets Ther       Date:  2020-01-07       Impact factor: 4.147

Review 3.  Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis.

Authors:  Xuelei Ma; Xiaoshan Wang; Jingwen Huang; Yingtai Chen; Jing Zhang; Binglan Zhang; Changle Shi; Lei Liu
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.